The estimated Net Worth of Paul Colvin is at least $3.92 Million dollars as of 1 February 2021. Mr. Colvin owns over 8,486 units of Syneos Health Inc stock worth over $1,215,260 and over the last 5 years he sold SYNH stock worth over $634,923. In addition, he makes $2,067,720 as President - Clinical Solutions at Syneos Health Inc.
Paul has made over 2 trades of the Syneos Health Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 8,486 units of SYNH stock worth $634,923 on 1 February 2021.
The largest trade he's ever made was selling 8,486 units of Syneos Health Inc stock on 1 February 2021 worth over $634,923. On average, Paul trades about 979 units every 32 days since 2020. As of 1 February 2021 he still owns at least 28,275 units of Syneos Health Inc stock.
You can see the complete history of Mr. Colvin stock trades at the bottom of the page.
Paul D. Colvin serves as President - Clinical Solutions of the Company. He has been our President, Clinical Solutions since December 2018. Prior to joining Syneos Health, Mr. Colvin held multiple leadership roles at PPD, a leading global CRO, from October 2007 to December 2018. From May 2010 to June 2016, Mr. Colvin served as Executive Vice President, Global Clinical Development, PPD. Mr. Colvin also served as Chairman and CEO of PPD-SNBL, a joint venture that grew to be one of the largest clinical development service providers in Japan, from December 2014 to December 2018. Mr. Colvin served as Executive Vice President, Biopharma Partnerships, PPD from June 2016 to December 2018. Prior to joining PPD, Mr. Colvin held various leadership positions at Eli Lilly and Company, a global pharmaceutical company, from January 1993 to October 2007. He received his Bachelor of Science in Pharmacy from Butler University. He is also a registered pharmacist and completed executive development programs at London Business School and the Center for Creative Leadership.
As the President - Clinical Solutions of Syneos Health Inc, the total compensation of Paul Colvin at Syneos Health Inc is $2,067,720. There are 2 executives at Syneos Health Inc getting paid more, with Alistair Macdonald having the highest compensation of $7,646,360.
Paul Colvin is 50, he's been the President - Clinical Solutions of Syneos Health Inc since 2019. There are 11 older and 7 younger executives at Syneos Health Inc. The oldest executive at Syneos Health Inc is William Klitgaard, 67, who is the Independent Director.
Paul's mailing address filed with the SEC is C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE, NC, 27560.
Over the last 7 years, insiders at Syneos Health Inc have traded over $16,280,601,287 worth of Syneos Health Inc stock and bought 17,946 units worth $873,496 . The most active insiders traders include Todd M Abbrecht, John L. Maldonado und Tom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of $83,067,962. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth $117,156.
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
Syneos Health Inc executives and other stock owners filed with the SEC include: